Weida Tong PhD U.S. FDA
Weida Tong PhD U.S. FDA Director, Division of Bioinformatics and Biostatistics, NCTR
Dr. Tong is the Director of Division of Bioinformatics and Biostatistics at NCTR/FDA. He is Senior Biomedical Research and Biomedical Product Assessment Service (SBRBPAS) Expert (formally Senior Biomedical Research Service) since 2011 at FDA. He has served Science Advisory Board for several multi-institutional projects in Europe and USA. He also holds adjunct appointment at several universities. He is the founder and board chairperson of international MAQC Society (2017-2020), President of MCBIOS Society (2019-2020), and Chair of SOT Board of Publication (2019-2020). He has published over 300 peer-reviewed papers from his roles in (1) Supervising and leading the FDA-led community wide MicroArray and SEquencing Quality Control (MAQC/SEQC) consortium to assess technical performance and practical utility of emerging genomic technologies with emphasis on regulatory application and precision medicine, (2) addressing the drug safety concerns related to drug-induced liver injury (DILI), (3) developing machine learning and AI for digital health and drug repositioning, and (4) conducting molecular modeling and QSARs on various toxicological endpoints such as carcinogenicity.